Effect of other T2DM medications (SGLT2 inhibitors, dipeptidyl peptidase-4 inhibitors, GLP-1 agonists) on LUTD in diabetes remains to be studied. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.